BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 21
• 22
• 23
• 24
• 27
• 28
• 29

• Policy

  Johnson & Johnson Hid Risperdal Studies to Boost Drug Sales, Lawyer Says

  February 3, 2012

   · 

  1 min read
• Business

  Cambrex Corporation to Announce Fourth Quarter 2011 Financial Results on February 6, 2012

  February 3, 2012

   · 

  1 min read
• Business

  Cytokinetics, Inc. Reports Fourth Quarter and Year End Highlights and 2011 Financial Results

  February 3, 2012

   · 

  23 min read
• BioMidwest

  Stryker Presents Results of the TREVO Prospective Clinical Study at the International Stroke Conference

  February 3, 2012

   · 

  2 min read
• Business

  InterMune, Inc. to Release Fourth Quarter and Full Year Financial Results on February 9

  February 3, 2012

   · 

  1 min read
• Drug Development

  GENFIT Corp. Release: The GFT505-210-6 Study Reaches All Its Efficacy Objectives With No Adverse Effects

  February 3, 2012

   · 

  6 min read
• Drug Development

  Positive Data Presented on Athersys, Inc.’ MultiStem to Treat Stroke

  February 3, 2012

   · 

  1 min read
• Deals

  Apricus Biosciences Announces Acquisition of NitroMist(TM) Rights Outside North America

  February 3, 2012

   · 

  1 min read
• Drug Development

  American Stroke Association Release: Warfarin and Aspirin are Similar in Heart Failure Treatment

  February 3, 2012

   · 

  1 min read
• American Stroke Association Release: Rare Mutations May Help Explain Aneurysm in High-Risk Families

  February 3, 2012

   · 

  1 min read